Znanstveni rad - Izvorni znanstveni rad
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes

Marso, Stiven P.; McGuire, Darren K.; Zinman, Bernard; Poulter, Neil R.; Emerson, Scott S.; Pieber, Thomas R.; Pratley, Richard E.; Haahr, Poul-Martin; Lange, Martin; Brown-Frandsen, Kirstine; Moses, Alan; Skibsted, Simone; Kvist, Kajsa; Buse, John B. (2017)
Citirajte ovaj rad

Marso, S. P., McGuire, D. K., Zinman, B., Poulter, N. R., Emerson, S. S., Pieber, T. R. ... Buse, J. B. (2017). Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes. New England Journal of Medicine, 377. (8), 723-732. doi: 10.1056/NEJMoa1615692

Marso, Stiven P., et al. "Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes." New England Journal of Medicine, vol. 377, br. 8, 2017, str. 723-732. https://doi.org/10.1056/NEJMoa1615692

Marso, Stiven P., Darren K. McGuire, Bernard Zinman, Neil R. Poulter, Scott S. Emerson, Thomas R. Pieber, Richard E. Pratley, et al. "Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes." New England Journal of Medicine 377, br. 8 (2017): 723-732. https://doi.org/10.1056/NEJMoa1615692

Marso, S. P., et al. (2017) 'Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes', New England Journal of Medicine, 377(8), str. 723-732. doi: 10.1056/NEJMoa1615692

Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, i sur.. Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes. New England Journal of Medicine [Internet]. 2017. [pristupljeno 19.11.2019.];377(8):723-732. doi: 10.1056/NEJMoa1615692

S. P. Marso, et al., "Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes", New England Journal of Medicine, vol. 377, br. 8, str. 723-732, 2017. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:239:882161. [Citirano: 19.11.2019.]